Authors: Wuthrich, RP Weinreich, T Ambuhl, PM Schwarzkopf, AK Candinas, D Binswanger, U

Citation: Rp. Wuthrich et al., Reduced kidney transplant rejection rate and pharmacoeconomic advantage ofmycophenolate mofetil, NEPH DIAL T, 14(2), 1999, pp. 394-399

Authors: Senn, B Rochat, P Schwarzkopf, AK Weinreich, T Binswanger, U

Citation: B. Senn et al., Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction, TRANSPLAN P, 30(8), 1998, pp. 4075-4076

Authors: Wuthrich, RP Weinreich, T Schwarzkopf, AK Candinas, D Binswanger, U

Citation: Rp. Wuthrich et al., Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation, TRANSPLAN P, 30(8), 1998, pp. 4096-4097